Multiplex rapid diagnostic test for simultaneous detection of SARS-CoV-2 antigen and influenza A/B viruses.
Manufactured by
Xiamen Biotime Biotechnology Co., Ltd.
China
Xiamen Biotime Biotechnology Co., Ltd. is a national high-tech enterprise specializing in R&D, manufacturing, and sales of in-vitro diagnostic reagents and instruments. Recognized as a National Specialized and Innovative "Little Giant" Enterprise and listed among China's Top 500 Private Manufacturing Enterprises. Technology platforms include chemiluminescence, molecular diagnostics, chromatography, mass spectrometry, dry chemistry, electrochemistry, fluorescence immunoassay, and colloidal gold. Products are exported to over 60 countries and regions.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Beijing Jinwofu Bioengineering Technology Co.,Ltd.
China · 4 relevant products
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 3 relevant products
Biopanda Reagents
United Kingdom · 3 relevant products
68 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 119 closest product alternatives
Beijing Jinwofu Bioengineering Technology Co.,Ltd. · China
A rapid antigen test kit for simultaneous detection of Influenza A, Influenza B, and COVID-19 (SARS-CoV-2). This combo test enables efficient screening for multiple respiratory viruses in a single procedure.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplex rapid antigen detection test that simultaneously identifies Influenza A, Influenza B, and SARS-CoV-2 from a single sample. This combo test provides comprehensive respiratory pathogen screening at the point of care.
Biopanda Reagents · United Kingdom
An immunochromatographic assay for qualitative detection of SARS-CoV-2 nucleocapsid protein and Influenza A+B virus antigens in nasal and nasopharyngeal swab samples. It is intended to assist in the diagnosis of SARS-CoV-2 and Influenza A+B infections in conjunction with other tests.
116 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products